Table 4 Review of the literature and pooled analysis of studies with reported histo-pathological outcome
Author, Date | N | Population | Analysis | Regression | Persistence | Progression |
|---|---|---|---|---|---|---|
Lurain [19] | 53 | Pregnant women with CIN I–III | Retrospective | 77.4 % | 22.6 % | 0 % |
Yost [7] | 153 | Pregnant women with CIN II–III | Retrospective | 69.3 % | 26.8 % | 3.9 % |
Palle [16] | 142 | Pregnant women with CIN I–III | Retrospective | 25 % | 47 % | 28 % |
Vlahos [8] | 78 | Pregnant women with CIN II–III | Retrospective | 61.6 % | 38.4 % | 0 % |
Paraskevaides [9] | 64 | Pregnant women with CIN II–III | Retrospective | 37.5 % | 59.4 % | 3.1 % |
Serati [15] | 36 | Pregnant women with CIN II–III | Prospective | 47.3 % | 52.7 % | 0 % |
Coppolillo [11] | 30 | Pregnant women with CIN II–III | Retrospective | 16.7 % | 70.0 % | 13.3 % |
Kärrberg [17] | 163 | Pregnant women with CIN I–III | Prospective | 33.1 % | 54.6 % | 12.3 % |
This study | 51 | Pregnant women with CIN I–III | Retrospective | 56.9 % | 39.2 % | 3.9 % |
Pooled analysis | 770 | Pregnant women with CIN I–III | Pooled | 46.8 % | 43.6 % | 9.6 % |